| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.604 (Beat by $0.084) |
| EPS GAAP Actual | $0.604 (Beat by $0.084) |
| Revenue Actual | $0.678026B |
| Revenue Surprise | Beat by $678.026M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.61867 |
| EPS GAAP Estimate | $0.61867 |
| Revenue Estimate | $0.759888237B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 6.7375 | 8.03 | 6.50793 | 7.0778 | 9 |
| Dec 2028 | 6.01667 | 8.99 | 5.80468 | 6.30322 | 7 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.76 | 0.20252 | 0.678026B | 2.3% | 10.17M |
| FQ2 2025 (Jun 2025) | 0.28 | -0.3126 | 0.672663B | 3.7% | -20.92M |
| FQ1 2025 (Mar 2025) | -0.49 | -0.49 | 0.651176B | 0.8% | 651.18M |
| FQ4 2024 (Dec 2024) | 1.16 | 1.16 | 0.852162B | 1.15% | 852.16M |
| FQ3 2024 (Sep 2024) | 0.5 | 0.5 | 0.66241B | 100% | 662.41M |
| FQ1 2013 (Mar 2013) | 0.0047 | 0.0047 | 0.026754B | 100% | 26.75M |
| FQ2 2013 (Jun 2013) | 0.0296 | 0.0296 | 0.027364B | 100% | 27.36M |
| FQ3 2013 (Sep 2013) | 0.0366 | 0.0366 | 0.029956B | 100% | 29.96M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.61867
Consensus Revenue Estimates
0.759888237B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.36148 | -- | 1.34275 | 1.4068 | 11 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 7 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 7 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 9 |
| FQ4 2026 (Oct 2026) | 0.61354 | -- | 0.59621 | 0.64001 | 6 |
| FQ3 2026 (Jul 2026) | 0.50053 | -51.84 | 0.48639 | 0.52213 | 11 |
| FQ2 2026 (Jun 2026) | 0.61152 | 54.21 | 0.59246 | 0.62861 | 5 |
| FQ1 2026 (Mar 2026) | 0.61867 | 179.2 | 0.59939 | 0.63596 | 11 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.93B | -- | 0.92B | 0.95B | 12 |
| FQ3 2027 (Sep 2027) | 0.72B | -- | 0.71B | 0.74B | 14 |
| FQ2 2027 (Jun 2027) | 0.71B | -- | 0.7B | 0.73B | 9 |
| FQ1 2027 (Mar 2027) | 0.69B | -- | 0.68B | 0.71B | 9 |
| FQ4 2026 (Oct 2026) | 0.73B | -- | 0.72B | 0.76B | 8 |
| FQ3 2026 (Jul 2026) | 0.72B | 6.19 | 0.71B | 0.75B | 13 |
| FQ2 2026 (Jun 2026) | 0.72B | 6.39 | 0.7B | 0.73B | 8 |
| FQ1 2026 (Mar 2026) | 0.76B | 14.31 | 0.74B | 0.78B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.55748 | 0.76 | 0.20252 | 26.65% |
| FQ2 2025 (Jun 2025) | 0.5926 | 0.28 | -0.3126 | -111.64% |
| FQ1 2025 (Mar 2025) | -0.49 | -0.49 | 100% | |
| FQ4 2024 (Dec 2024) | 1.16 | 1.16 | 100% | |
| FQ3 2024 (Sep 2024) | 0.5 | 0.5 | 100% | |
| FQ1 2013 (Mar 2013) | 0.0047 | 0.0047 | 100% | |
| FQ2 2013 (Jun 2013) | 0.0296 | 0.0296 | 100% | |
| FQ3 2013 (Sep 2013) | 0.0366 | 0.0366 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.67B | $0.68B | $10.17M | 1.5% |
| FQ2 2025 (Jun 2025) | $0.69B | $0.67B | $-20.92M | -3.11% |
| FQ1 2025 (Mar 2025) | $0B | $0.65B | $651.18M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.85B | $852.16M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.66B | $662.41M | 100% |
| FQ1 2013 (Mar 2013) | $0B | $0.03B | $26.75M | 100% |
| FQ2 2013 (Jun 2013) | $0B | $0.03B | $27.36M | 100% |
| FQ3 2013 (Sep 2013) | $0B | $0.03B | $29.96M | 100% |